SIGA Technologies Inc (SIGA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $196.88M
Last updated: Nov 17, 2026 at 11:05 AM ET
SIGA Technologies Inc (SIGA) P/E Ratio & Valuation History
SIGA Technologies (SIGA) trades at 475.0x trailing earnings. Its P/E of 475.0x is above its 5-year median of 8.1x. Its forward P/E is 2.5x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 18900.0% higher over the next year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 475.0x |
| Forward P/E | 2.5x |
| Price to book | 1.3x |
| PEG | 3.4 |
Historical Medians
Against its 10-year medians, its P/B is 64.9% below 3.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 475.0x | 8.1x | N/A |
| P/S | N/A | 3.8x | 4.4x |
| P/B | 1.3x | 2.9x | 3.7x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 1.5x in 2018 to 19.1x in 2025. 2025 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $6.11 | 19.1x | 4.6x | 2.2x |
| 2024 | $6.01 | 7.3x | 3.1x | 2.0x |
| 2023 | $5.60 | 5.9x | 2.8x | 2.0x |
| 2022 | $7.36 | 16.0x | 4.8x | 3.1x |
| 2021 | $7.52 | 8.2x | 4.2x | 3.2x |
| 2020 | $7.27 | 10.1x | 4.6x | 4.4x |
| 2019 | $4.77 | N/A | 14.5x | 4.0x |
| 2018 | $7.90 | 1.5x | 1.3x | 6.2x |
| 2017 | $4.85 | N/A | 31.2x | N/A |
| 2016 | $2.88 | N/A | 12.2x | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SIGA
What is SIGA's forward P/E ratio?
SIGA Technologies has a forward P/E ratio of 2.5x.
Is SIGA stock overvalued?
GNG's valuation label for SIGA is Undervalued.
What is SIGA Technologies's average P/E ratio over 5 years?
SIGA Technologies's median P/E over the last 5 years is 8.1x, from 54 month-end values through Oct 2026.
What is SIGA's PEG ratio?
SIGA Technologies has a PEG ratio of 3.4.
SIGA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors